Netris Pharma
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$8.2M
Netris Pharma is a clinical-stage biopharmaceutical company focused on developing anti-cancer therapeutics, particularly its lead product NP137, which is designed to enhance the effectiveness of oncology treatments by overcoming drug resistance.